Age (mean ± SD) |
48.2 ± 13.8 |
50.5 ± 12.4 |
47.95 ± 15.2 |
46.35 ± 14.1 |
0.68 |
Gender n (%) |
|
0.49 |
Male |
42 (70) |
13 (65) |
16 (80) |
13 (65) |
|
Female |
18 (30) |
7 (35) |
4 (20) |
7 (35) |
|
BMI (mean ± SD) |
29.06 ± 4.3 |
29.8 ± 3.5 |
28.6 ± 5.3 |
28.6 ± 4.1 |
0.46 |
Comorbidity n (%) |
24 (40) |
8 (40) |
9 (45) |
7 (35) |
0.81 |
DM |
8 (13.3) |
4 (20) |
1 (5) |
3 (15) |
|
HT |
5 (8.3) |
2 (10) |
3 (15) |
0 |
|
HT + DM |
5 (8.3) |
2 (10) |
1 (5) |
2 (10) |
|
Other |
6 (10) |
0 |
4 (20) |
2 (10) |
|
Drug use n (%) |
0.93 |
Yes |
7 (35) |
8 (40) |
8 (40) |
7 (35) |
|
No |
13 (65) |
12 (60) |
12 (60) |
13 (65) |
|
Anticoagulant n (%) |
0.15 |
|
|
|
|
Yes |
4 (6.7) |
0 |
3 (15) |
1 (5) |
|
No |
56 (93.3) |
20 (100) |
17 (85) |
19 (95) |
|
Previous Stone surgery n (%) |
0.80 |
Yes |
21 (35) |
7 (35) |
6 (30) |
8 (40) |
|
No |
39 (65) |
13 (65) |
14 (70) |
12 (60) |
|
Stone related parameters |
|
Stone size (mm) (mean ± SD) |
14.08 ± 5.4 |
14.95 ± 6.5 |
14.65 ± 5.6 |
12.65 ± 3.6 |
0.48 |
Stone density (HU) (mean ± SD) |
950 ± 289 |
1002 ± 331 |
919 ± 263 |
929 ± 278 |
0.57 |
Stone side n (%) |
0.41 |
Right |
39 (65) |
9 (45) |
5 (25) |
7 (35) |
|
Left |
21 (35) |
11 (55) |
15 (75) |
13 (65) |
|
Stone localization n (%) |
0.89 |
Upper pole |
5 (8.3) |
2 (10) |
1 (5) |
2 (10) |
|
Mid pole |
12 (20) |
3 (15) |
5 (25) |
4 (20) |
|
Lower pole |
14 (23.3) |
5 (25) |
6 (30) |
3 (15) |
|
Renal pelvis |
12 (20) |
5 (25) |
2 (10) |
5 (25) |
|
Multiple |
17 (28.3) |
5 (25) |
6 (30) |
6 (30) |
|
Lower pole infindubulopelvic angle (°) (mean) |
51.6 (32–90) |
49.05(35–85) |
52.05 (32–90) |
53.95 (32–78) |
0.44 |
Surgery related parameters |
|
Fluoroscopy time (sec) (mean ± SD) |
40.7 ± 22.6 |
41.4 ± 26.4 |
41.2 ± 24.6 |
39.6 ± 17.1 |
0.98 |
Operation time (min) (mean ± SD) |
62.8 ± 16.5 |
65 ± 14.9 |
63 ± 19.9 |
60.5 ± 14.7 |
0.55 |
Length of stay in hospital (day) (mean ± SD) |
1.62 ± 1.53 |
1.75 ± 1.83 |
1.55 ± 1.39 |
1.55 ± 1.39 |
0.99 |
Stone free rate n (%) |
54 (90) |
17 (85) |
19 (95) |
18 (90) |
0.57 |
DJ stent insertion n (%) |
0.59 |
Yes |
58 (96.6) |
19 (95) |
20 (100) |
19 (95) |
|
No |
2 (3.4) |
1 (5) |
0 |
1 (5) |
|
PULS grade n (%) |
0.84 |
0 |
43 (71.7) |
15 (75) |
13 (65) |
15 (75) |
|
1 |
12 (20) |
4 (20) |
4 (20) |
4 (20) |
|
2 |
4 (6.7) |
1 (5) |
2 (10) |
1 (5) |
|
3 |
1 (1.7) |
0 |
1 (5) |
0 |
|
4–5 |
0 |
0 |
0 |
0 |
|
Postoperative complication (modified Clavien classification) n (%) |
0.19 |
0 |
54 (90) |
18 (90) |
18 (90) |
18 (90) |
|
1 |
4 (6.7) |
2 (10) |
0 |
2 (10) |
|
2 |
2 (3.3) |
0 |
2 (10) |
0 |
|
3–4–5 |
0 |
0 |
0 |
0 |
|
Postoperative fever n (%) |
0.25 |
Yes |
5 (%8.3) |
2 (%10) |
2 (%10) |
1 (%5) |
|
No |
55 (%91.7) |
18 (%90) |
18 (%90) |
19 (%95) |
|
Preoperative serum creatinin level (mg/dl) |
0.87±0.22 |
0.84±0.20 |
0.89±0.22 |
0.82±0.20 |
0.77 |
Postoperative 4th hour serum creatinin level (mg/dl) |
0.91±0.23 |
0.93±0.22 |
0.98±0.25 |
0.87±0.17 |
0.79 |
Postoperative 14th day serum creatinin level (mg/dl) |
0.85±0.18 |
0.89±0.27 |
0.90±0.24 |
0.85±0.19 |
0.65 |